骨同种异体移植市场－全球产业规模、份额、趋势、机会和预测，按应用、按类型、按最终用户、按地区和竞争进行细分，2020-2030 年预测

2024 年全球骨移植市场价值为 14.5 亿美元，预计在预测期内将实现令人瞩目的成长，到 2030 年的复合年增长率为 7.25%。近年来，受人口老化加剧、骨科疾病病例增加和医疗技术进步的推动，全球骨移植市场经历了大幅成长。骨同种异体移植涉及将骨组织从捐赠者移植到接受者，已成为骨科和牙科手术的重要组成部分。骨同种异体移植是来自人类捐赠者的组织移植，可用于各种骨科和牙科应用。它们主要用于治疗骨缺损、骨折、脊椎融合、关节重建和牙科手术。骨同种异体移植是自体移植（来自患者自身身体的骨组织）的可行替代方案，由于其能够促进骨癒合、减轻疼痛和缩短恢復时间而广受欢迎。根据 2024 年的一篇文章，估计英国 75 至 84 岁人口中约有 63% 患有肌肉骨骼疾病，是所有年龄层中患病率最高的。整体而言，肌肉骨骼疾病的盛行率随着年龄的增长而上升，对老年人口的影响显着。

骨关节炎、骨折、脊椎畸形等骨科疾病的全球盛行率正在上升。这种趋势推动了对骨同种异体移植的需求，因为它们对于解决这些病症的外科手术至关重要。微创手术和机器人辅助手术等外科手术技术的进步增加了骨同种异体移植的采用。这些技术提高了骨移植手术的精确度和有效性。老化人口容易出现与年龄相关的骨骼问题，例如骨质疏鬆症和退化性关节疾病。随着老龄人口不断增长，预计骨同种异体移植的需求将大幅上升。严格的组织移植监管框架提高了骨移植的安全性和品质。这增强了消费者信心和市场成长。随着患者和医疗专业人员对骨移植益处的认识不断提高，此类移植在外科手术中的接受度和利用率也不断提高。

主要市场驱动因素

肌肉骨骼疾病发生率上升推动全球骨移植市场发展

主要市场挑战

供应链约束

主要市场趋势

技术进步

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球骨同种异体移植市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按应用分类（牙科、脊椎、重建和创伤学、其他）
  • 依类型（皮质骨同种异体移植、鬆质骨同种异体移植、皮质鬆质骨同种异体移植、脱矿骨基质）
  • 按最终使用者（医院和牙科诊所、骨科和创伤中心、其他）
  • 按地区
  • 按公司划分（前五大市场参与者的份额，2024 年）
• 市场地图
  • 按应用
  • 按类型
  • 按最终用户
  • 按地区

第 6 章：北美骨同种异体移植市场展望

• 市场规模和预测
• 市场占有率和预测

第 7 章：欧洲骨同种异体移植市场展望

• 市场规模和预测
• 市场占有率和预测

第 8 章：亚太地区骨移植市场展望

• 市场规模和预测
• 市场占有率和预测

第 9 章：南美洲骨移植市场展望

• 市场规模和预测
• 市场占有率和预测

第 10 章：中东和非洲骨移植市场展望

• 市场规模和预测
• 市场占有率和预测

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 合併与收购
• 应用程式启动

第 13 章：竞争格局

• Zimmer Biomet inc.
• Medtronic inc.
• Lynch Biologics, LLC
• Biomatlante SA
• Stryker Corporation
• Royal Biologics, Inc.
• Johnsons & Johnsons
• Smith & Nephew plc
• Baxter International Inc
• Xtant Medical Hldgs.

第 14 章：策略建议

第15章调查会社について・免责事项

The Global Bone Allografts Market was valued at USD 1.45 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.25% through 2030. The global bone allografts market has witnessed substantial growth in recent years, driven by an increasing aging population, rising cases of orthopedic disorders, and advancements in medical technology. Bone allografts, which involve the transplantation of bone tissue from a donor to a recipient, have become a crucial part of orthopedic and dental procedures. Bone allografts are tissue grafts sourced from a human donor and are used for various orthopedic and dental applications. They are primarily employed in surgeries to treat bone defects, fractures, spinal fusion, joint reconstruction, and dental procedures. Bone allografts serve as a viable alternative to autografts (bone tissue from the patient's own body) and have gained popularity due to their ability to promote bone healing and reduce pain and recovery time. According to a 2024 article, an estimated 63% of individuals aged 75 to 84 in the United Kingdom were living with a musculoskeletal condition, the highest prevalence among all age groups. Overall, the prevalence of musculoskeletal conditions tends to rise with age, highlighting the significant impact on the elderly population.

The global prevalence of orthopedic disorders, including osteoarthritis, fractures, and spinal deformities, is on the rise. This trend has fueled the demand for bone allografts, as they are crucial in surgical interventions to address these conditions. Technological advancements in surgical techniques, such as minimally invasive surgeries and robotic-assisted procedures, have increased the adoption of bone allografts. These techniques enhance the precision and efficacy of bone grafting procedures. The aging population is prone to age-related bone issues, such as osteoporosis and degenerative joint diseases. As the elderly population continues to grow, the demand for bone allografts is expected to rise significantly. Stringent regulatory frameworks governing tissue transplantation have improved the safety and quality of bone allografts. This has bolstered consumer confidence and market growth. Increased awareness among both patients and healthcare professionals about the benefits of bone allografts has led to higher acceptance and utilization of these grafts in surgical procedures.

Key Market Drivers

Rising Incidence of Musculoskeletal Disorders is Driving the Global Bone Allografts Market

Musculoskeletal disorders have become a significant global health concern, affecting millions of people across the world. These disorders encompass a wide range of conditions that impact the muscles, bones, tendons, ligaments, and other parts of the musculoskeletal system. Conditions like osteoarthritis, osteoporosis, fractures, and spinal disorders have been on the rise due to various factors such as aging populations and sedentary lifestyles. To address the growing demand for musculoskeletal treatments, the global bone allografts market is experiencing remarkable growth.

Musculoskeletal disorders represent a wide spectrum of health issues, and their prevalence is increasing at an alarming rate globally. As the world's population ages, the incidence of musculoskeletal disorders, particularly osteoarthritis and osteoporosis, is rising. Aging leads to a natural loss of bone density and muscle mass, making individuals more susceptible to fractures and joint degeneration. Modern lifestyles often involve extended periods of sitting, limited physical activity, and poor posture. These factors can contribute to muscle imbalances and musculoskeletal problems, including back pain and repetitive strain injuries. Obesity is a significant risk factor for musculoskeletal disorders. Excess weight places additional stress on joints, leading to conditions like osteoarthritis and lower back pain. Jobs that involve repetitive motions, heavy lifting, or prolonged periods of standing can lead to musculoskeletal injuries. Workers in industries like construction, healthcare, and manufacturing are at a higher risk. Participation in sports and physical activities carries a risk of injury, including fractures and ligament tears, which can contribute to the overall burden of musculoskeletal disorders.

Key Market Challenges

Supply Chain Constraints

One of the primary challenges facing the bone allografts market is the consistent and reliable supply of graft materials. The availability of suitable donor tissues can be affected by factors such as changes in regulations, limitations on donor pool size, and disruptions in the supply chain due to natural disasters or health crises like the COVID-19 pandemic. Ensuring a stable supply chain is essential to meet the growing demand for bone allografts.

Key Market Trends

Technological Advancements

Technological advancements have always been a catalyst for innovation and growth in various industries, and the healthcare sector is no exception. In recent years, the global bone allografts market has witnessed a remarkable surge in demand, thanks to the continuous evolution of cutting-edge technologies. Bone allografts, which involve the transplantation of bone tissue from a donor to a recipient, have become a crucial component in various orthopedic and dental procedures. Also, the partnership between two companies leads to the growth of global bone allografts market. For instance, in August 2022, Orthofix Medical Inc., a medical device company, collaborated with CGBio, a developer of synthetic bone grafts, to commercialize and advance the clinical development of Novosis recombinant human bone morphogenetic protein-2 (rhBMP-2) in the U.S. and Canadian markets.

Key Market Players

• Zimmer Biomet inc.
• Medtronic inc.
• Lynch Biologics, LLC
• Biomatlante S.A
• Stryker Corporation
• Royal Biologics, Inc.
• Johnsons & Johnsons
• Smith & Nephew plc
• Baxter International Inc
• Xtant Medical Hldgs.

Report Scope:

In this report, the Global Bone Allografts Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bone Allografts Market, By Application:

• Dental
• Spine
• Reconstruction & Traumatology
• Others

Bone Allografts Market, By Type:

• Cortical Bone Allografts
• Cancellous Bone Allografts
• Corticocancellous Bone Allografts
• Demineralized bone Matrices

Bone Allografts Market, By End-user:

• Hospitals & Dental Clinics
• Orthopedic & Trauma Centers
• Others

Bone Allografts Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bone Allografts Market.

Available Customizations:

Global Bone Allografts market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bone Allografts Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Dental, Spine, Reconstruction & Traumatology, Others)
  • 5.2.2. By Type (Cortical Bone Allografts, Cancellous Bone Allografts, Corticocancellous Bone Allografts, Demineralized bone Matrices)
  • 5.2.3. By End-user (Hospitals & Dental Clinics, Orthopedic & Trauma Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (Shares of Top 5 Market Players, 2024)
• 5.3. Market Map
  • 5.3.1. By Application
  • 5.3.2. By Type
  • 5.3.3. By End user
  • 5.3.4. By Region

6. North America Bone Allografts Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Type
  • 6.2.3. By End user
  • 6.2.4. By Country
    • 6.2.4.1. United States Bone Allografts Market Outlook
      • 6.2.4.1.1. Market Size & Forecast
      • 6.2.4.1.1.1. By Value
      • 6.2.4.1.2. Market Share & Forecast
      • 6.2.4.1.2.1. By Application
      • 6.2.4.1.2.2. By Type
      • 6.2.4.1.2.3. By End user
    • 6.2.4.2. Canada Bone Allografts Market Outlook
      • 6.2.4.2.1. Market Size & Forecast
      • 6.2.4.2.1.1. By Value
      • 6.2.4.2.2. Market Share & Forecast
      • 6.2.4.2.2.1. By Application
      • 6.2.4.2.2.2. By Type
      • 6.2.4.2.2.3. By End user
    • 6.2.4.3. Mexico Bone Allografts Market Outlook
      • 6.2.4.3.1. Market Size & Forecast
      • 6.2.4.3.1.1. By Value
      • 6.2.4.3.2. Market Share & Forecast
      • 6.2.4.3.2.1. By Application
      • 6.2.4.3.2.2. By Type
      • 6.2.4.3.2.3. By End user

7. Europe Bone Allografts Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Type
  • 7.2.3. By End user
  • 7.2.4. By Country
    • 7.2.4.1. France Bone Allografts Market Outlook
      • 7.2.4.1.1. Market Size & Forecast
      • 7.2.4.1.1.1. By Value
      • 7.2.4.1.2. Market Share & Forecast
      • 7.2.4.1.2.1. By Application
      • 7.2.4.1.2.2. By Type
      • 7.2.4.1.2.3. By End user
    • 7.2.4.2. Germany Bone Allografts Market Outlook
      • 7.2.4.2.1. Market Size & Forecast
      • 7.2.4.2.1.1. By Value
      • 7.2.4.2.2. Market Share & Forecast
      • 7.2.4.2.2.1. By Application
      • 7.2.4.2.2.2. By Type
      • 7.2.4.2.2.3. By End user
    • 7.2.4.3. United Kingdom Bone Allografts Market Outlook
      • 7.2.4.3.1. Market Size & Forecast
      • 7.2.4.3.1.1. By Value
      • 7.2.4.3.2. Market Share & Forecast
      • 7.2.4.3.2.1. By Application
      • 7.2.4.3.2.2. By Type
      • 7.2.4.3.2.3. By End user
    • 7.2.4.4. Italy Bone Allografts Market Outlook
      • 7.2.4.4.1. Market Size & Forecast
      • 7.2.4.4.1.1. By Value
      • 7.2.4.4.2. Market Share & Forecast
      • 7.2.4.4.2.1. By Application
      • 7.2.4.4.2.2. By Type
      • 7.2.4.4.2.3. By End user
    • 7.2.4.5. Spain Bone Allografts Market Outlook
      • 7.2.4.5.1. Market Size & Forecast
      • 7.2.4.5.1.1. By Value
      • 7.2.4.5.2. Market Share & Forecast
      • 7.2.4.5.2.1. By Application
      • 7.2.4.5.2.2. By Type
      • 7.2.4.5.2.3. By End user

8. Asia Pacific Bone Allografts Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Type
  • 8.2.3. By End user
  • 8.2.4. By Country
    • 8.2.4.1. China Bone Allografts Market Outlook
      • 8.2.4.1.1. Market Size & Forecast
      • 8.2.4.1.1.1. By Value
      • 8.2.4.1.2. Market Share & Forecast
      • 8.2.4.1.2.1. By Application
      • 8.2.4.1.2.2. By Type
      • 8.2.4.1.2.3. By Application
    • 8.2.4.2. India Bone Allografts Market Outlook
      • 8.2.4.2.1. Market Size & Forecast
      • 8.2.4.2.1.1. By Value
      • 8.2.4.2.2. Market Share & Forecast
      • 8.2.4.2.2.1. By Application
      • 8.2.4.2.2.2. By Type
      • 8.2.4.2.2.3. By End user
    • 8.2.4.3. South Korea Bone Allografts Market Outlook
      • 8.2.4.3.1. Market Size & Forecast
      • 8.2.4.3.1.1. By Value
      • 8.2.4.3.2. Market Share & Forecast
      • 8.2.4.3.2.1. By Application
      • 8.2.4.3.2.2. By Type
      • 8.2.4.3.2.3. By End user
    • 8.2.4.4. Japan Bone Allografts Market Outlook
      • 8.2.4.4.1. Market Size & Forecast
      • 8.2.4.4.1.1. By Value
      • 8.2.4.4.2. Market Share & Forecast
      • 8.2.4.4.2.1. By Application
      • 8.2.4.4.2.2. By Type
      • 8.2.4.4.2.3. By End user
    • 8.2.4.5. Australia Bone Allografts Market Outlook
      • 8.2.4.5.1. Market Size & Forecast
      • 8.2.4.5.1.1. By Value
      • 8.2.4.5.2. Market Share & Forecast
      • 8.2.4.5.2.1. By Application
      • 8.2.4.5.2.2. By Type
      • 8.2.4.5.2.3. By End user

9. South America Bone Allografts Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Type
  • 9.2.3. By End user
  • 9.2.4. By Country
    • 9.2.4.1. Brazil Bone Allografts Market Outlook
      • 9.2.4.1.1. Market Size & Forecast
      • 9.2.4.1.1.1. By Value
      • 9.2.4.1.2. Market Share & Forecast
      • 9.2.4.1.2.1. By Application
      • 9.2.4.1.2.2. By Type
      • 9.2.4.1.2.3. By End user
    • 9.2.4.2. Argentina Bone Allografts Market Outlook
      • 9.2.4.2.1. Market Size & Forecast
      • 9.2.4.2.1.1. By Value
      • 9.2.4.2.2. Market Share & Forecast
      • 9.2.4.2.2.1. By Application
      • 9.2.4.2.2.2. By Type
      • 9.2.4.2.2.3. By End user
    • 9.2.4.3. Colombia Bone Allografts Market Outlook
      • 9.2.4.3.1. Market Size & Forecast
      • 9.2.4.3.1.1. By Value
      • 9.2.4.3.2. Market Share & Forecast
      • 9.2.4.3.2.1. By Application
      • 9.2.4.3.2.2. By Type
      • 9.2.4.3.2.3. By End user

10. Middle East & Africa Bone Allografts Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Type
  • 10.2.3. By End user
  • 10.2.4. By Country
    • 10.2.4.1. South Africa Bone Allografts Market Outlook
      • 10.2.4.1.1. Market Size & Forecast
      • 10.2.4.1.1.1. By Value
      • 10.2.4.1.2. Market Share & Forecast
      • 10.2.4.1.2.1. By Application
      • 10.2.4.1.2.2. By Type
      • 10.2.4.1.2.3. By End user
    • 10.2.4.2. Saudi Arabia Bone Allografts Market Outlook
      • 10.2.4.2.1. Market Size & Forecast
      • 10.2.4.2.1.1. By Value
      • 10.2.4.2.2. Market Share & Forecast
      • 10.2.4.2.2.1. By Application
      • 10.2.4.2.2.2. By Type
      • 10.2.4.2.2.3. By End user
    • 10.2.4.3. UAE Bone Allografts Market Outlook
      • 10.2.4.3.1. Market Size & Forecast
      • 10.2.4.3.1.1. By Value
      • 10.2.4.3.2. Market Share & Forecast
      • 10.2.4.3.2.1. By Application
      • 10.2.4.3.2.2. By Type
      • 10.2.4.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Application Launches

13. Competitive Landscape

• 13.1. Zimmer Biomet inc.
• 13.2. Medtronic inc.
• 13.3. Lynch Biologics, LLC
• 13.4. Biomatlante S.A
• 13.5. Stryker Corporation
• 13.6. Royal Biologics, Inc.
• 13.7. Johnsons & Johnsons
• 13.8. Smith & Nephew plc
• 13.9. Baxter International Inc
• 13.10. Xtant Medical Hldgs.

14. Strategic Recommendations

15. About us & Disclaimer